Omeros (OMER) Operating Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,895.00 |
| Sep 30, 2021 | -2,611.00 |
| Jun 30, 2021 | -4,900.00 |
| Mar 31, 2021 | 4,715.00 |
| Dec 31, 2020 | -4,780.00 |
| Sep 30, 2020 | 49,486.00 |
| Jun 30, 2020 | 29,642.00 |
| Mar 31, 2020 | 452,054.00 |
| Dec 31, 2019 | 1.10 Mn |
| Sep 30, 2019 | 796,843.00 |
| Jun 30, 2019 | 3.82 Mn |
| Mar 31, 2019 | 1.56 Mn |
| Dec 31, 2018 | 814,213.00 |
| Sep 30, 2018 | 608,494.00 |
| Jun 30, 2018 | 755,003.00 |
| Mar 31, 2018 | -82,857.00 |
| Dec 31, 2017 | 37,325.00 |
| Sep 30, 2017 | 89,638.00 |
| Jun 30, 2017 | 47,062.00 |
| Mar 31, 2017 | 43,575.00 |
| Dec 31, 2016 | 76,963.00 |
| Sep 30, 2016 | 51,788.00 |
| Jun 30, 2016 | 31,924.00 |
| Mar 31, 2016 | 25,839.00 |
| Dec 31, 2015 | 60,648.00 |
| Sep 30, 2015 | 235,658.00 |
| Jun 30, 2015 | 103,501.00 |